Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anxiety Disorders
Data from Selcuk University advance knowledge in anxiety disorders
May 21st, 2008
According to recent research from Meram, Turkey, "This study aims to investigate the current prevalences of mood and anxiety disorders, as well as the socio-demographic and clinical features associated with these disorders in multiple sclerosis (MS). A total of 74 patients with relapsing-remitting MS (42 patients in exacerbation phase, 32 patients in remission phase) were included in the study." "Mood and anxiety disorders were diagnosed by means of the Structured Clinical Interview for DSM-IV (SCID-I). The Expanded Disability Status Scale (EDSS) was used to determine degree of disability due to MS. Forty-five (60.8%) patients met the criterion of at least one mood or...
Source: Immunotherapy Weekly (2008-05-21)
|
